What happens when the healthcare system fails the people it’s meant to protect? In the 1970s and 1980s, thousands of UK ...

A study links lower levels of the inhibitory neurotransmitter GABA to neuropathic pain in people with HIV, offering insight into potential pain mechanisms.

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

All adults who have blood taken as part of their treatment will have the sample tested for HIV, hepatitis B and hepatitis C, ...

A Lehigh Valley company that helped transform HIV testing is continuing its mission to improve public health through innovation and accessibility.

Dr. Brandon Hill, CEO of Vivent Health and a researcher in HIV and sexual issues, talks about changes in government funding.

After nearly a decade of research and development, a Madison company is launching an innovative blood test that can detect cancers. Exact Sciences Corp., the maker of Cologuard, a home collection kit ...

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial ...

The ADAPT (Alzheimer’s Disease Diagnosis and Plasma pTau217) team, led by Professor Jonathan Schott and Dr. Ashvini Keshavan, is investigating whether a blood test that measures the protein p-tau217 ...

WASHINGTON (AP) — Lyme disease can cause serious harm, but so can bogus tests and treatments. The complexity of diagnosing the tick-borne disease has given rise to an entire industry of unapproved ...

Blood draws for several kinds of diagnostic tests require you to fast for several hours. Eating or drinking anything besides water can skew the results, leading to you needing to be retested. You may ...